Research Activities
2015 A Phase 4, Double-Blind, Randomized,
Placebo-Controlled, Parallel Group, Multi-Center Study to Evaluate the
Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with
Overactive Bladder (OAB) – PILLAR. Co-Investigator
(Ottawa Site)
2015 Group
education and decision coaching in women’s pelvic health: A Randomized Control
Trial.
Co-Investigator
2014 - 2015 Cost of unintended pregnancies and the impact
of increase use of long-acting reversible contraceptives in Canada.
Principal
Investigator.
Funded in part
through Eunice Kennedy Shriver National Institute of Child Health and Human
Development grant for Infrastructure for Population Research at Princeton University,
Grant R24HD047879 (Dr. James Trussell).
2014 - 2016 A Randomized, Parallel-Group, Double-Blind,
placebo-controlled, multi-center study to Assess the Efficacy and Safety of
Difference doses of BAY 1002670 in Subjects with Uterine Fibroids over 3 months. Co-Investigator (Ottawa
Site)
2014 - 2016 Effect of Folic Acid Supplementation in Pregnancy
on Preeclampsia – Folic Acid Clinical Trial (FACT). Canadian Institutes of Health Research
(CIHR). Principal Investigators: Dr. Mark Walker, Dr. Shi Wu Wen (Ottawa) Co-Investigator (Ottawa
site) 2014 - 2016 A Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study to
Evaluate the Efficacy and Safety of Ulipristal Acetate for the Intermittent
Treatment of Abnormal Uterine Bleeding associated with Leiomyomas. Watson/Actavis.
Co-Investigator (Ottawa site)
2014- Extension Study to Evaluate the Long-Term
Safety and Efficacy of Elagolix in Subjects with Moderate to Severe
Endometriosis-Associated Pain. Co-Investigator (Ottawa site)
2013- 2015 Immunization
of Women with Diphtheria and Tetanus Toxoids Combined with Acellular Pertussis
(Tdap) During the Mid Third Trimester of Pregnancy: An Evaluation of the
Potential for Immunological Protection for the Neonate
Co-Investigator (Ottawa site)
2012- 2015 A
Randomized, Double Blind, Placebo
Controlled Study to Evaluate the Safety and Efficacy
of Elagolix in Subjects with Endometriosis Associated Pain. OHREB Approved
Co-Investigator (Ottawa site)
2012-2014 Health
Advocacy Training in Postgraduate Obstetrics and Gynecology: Evaluation of a
New
Curriculum
Through OSCE’s.
Co-investigator
Grant: Physician’s Services
Incorporated Foundation Resident Grant
2010-2012 Evaluation
of A Unique Canadian Community Outreach Program Providing Obstetrical Care for
Pregnant Adolescents: A Matched Cohort
Study. Co-Investigator
Support: The TOHAMO Innovation Award
2009-2012 Teaching
Health Advocacy in Ob/Gyn Residency at the University of Ottawa.
Co-Investigator
Support: The Educational Initiatives in Residency
Education Fund, University of Ottawa.
2009-2012 Multi-centre,
randomized, double-blind, active controlled, parallel group, 2-arm study to
show superiority of the oral contraceptive SH T00658ID to Ortho Tri-Cyclen Lo
on hormone withdrawal-associated symptoms after 6 cycles of treatment.
Primary
Investigator (Ottawa Site)
2009 A
National Survey of Sources of Health Information in Canada. Support: The Society of Obstetricians and
Gynecologists of Canada’s Contraception Awareness Program. Principal Investigator
2009 Comparison of the Continuous Versus Cyclic Use of a 30-mcg Ethinyl
Estradiol/0.15-mg Desogestrel Oral Contraceptive Pill in Adolescents.
Primary Investigator (Ottawa
Site) Support: Physicians
Services Incorporated (PSI) grant
2009 Characteristics of Women Undergoing Repeat Abortion: 10 Year
Follow Up. Co-Investigator. In
collaboration with Drs. W. Fisher and P. Shuper, The University of
Western
Ontario, London, Ontario.
2007 A National Landscape Survey of Contraceptive
Patterns and Sexual Behaviours in
Canadian Women.
Primary
Investigator.
Support: The Society of Obstetricians and
Gynaecologists of Canada Contraception Awareness Program
2007 Travel
to Access Reproductive Health Services Study. Consultant
Ob/Gyn as medical expert in contraception and pregnancy termination
Primary Investigator: Professor C. Sethna, University of Ottawa
(grant holder)
Support: Social Sciences and Humanities Research
Council Grant
2007 Multi-center, open-label, randomized study
to assess the safety and contraceptive efficacy
of
two doses (in vitro 12 µg/24 h and 16 µg /24 h) of the ultra low dose
levonorgestrel contraceptive intrauterine systems (LCS) for a maximum of 3
years in women 18 to 35 years of age.
Primary Investigator (Ottawa Site)
2006-2009
A
Randomized, Open-Label, Comparative, Multi-Center Trial to Evaluate Contraceptive
Efficacy, Cycle Control, Safety, and Acceptability of a Monophasic Combined
Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5
mg Estradiol (E2), Compared to a Monophasic COC Containing 3 mg Drosperinone
(DRSP) and 30 mcg Ethinyl Estradiol (EE). Primary Investigator,
Ottawa Site
OTHER RESEARCH
2016 - Testing HIV Curative Strategies in a
Humanized Mouse Model. Co-investigator (Principal Investigator: Dr. Jonathan Angel
2014 - Understanding the molecular basis
of placental mediated diseases. Co-Investigator.
(Primary Investigator: Dr. Shannon
Bainbridge)
2014 – 2016 Improving maternal health in India and Canada through
knowledge building and
participatory
design of educational material on upright birthing positions. Collaborator
2012 - Implementation of an HPV
Catch-Up Vaccination Program in High-Risk Adolescent Women. Co-Investigator
2012 -
2013
Using Photovoice as a Strategy to
Elicit the Determinants of Reproductive and Sexual
Health that
Impact Adolescent Mothers.
Co-Investigator
2012 - 2013 Objective Assessment of a Pediatric and
Adolescent Gynecology Simulation Curriculum via Pre and Post- Objective
Structured Clinical Examinations.
Co-Investigator
2012- 2014 Assessing
the Need for an HPV Catch-Up Vaccination Program in Higher-Risk Adolescent
Women.
Co-Investigator
2012 - Rates
of Sexually Transmitted Infections in Pregnant Canadian Adolescents: A
Prospective Cohort Study.
Principal
Investigator
2012
- 2014 Knowledge and Understanding of Epidemiological Principles in Canadian
Postgraduate Trainees.
Principal
Investigator
2010 Contraceptive Use Among Canadian Adolescent Women: Patterns, Adherence, and Barriers to Use
Principal Investigator
2010 Temporary Uterine Artery Embolization Prior to Elective Uterine
Myomectomy: A case series
Principal
Investigator
2009-2012 Violence
in Adolescent Pregnancy in Canada: A
prospective cohort study.
Co-investigator
2009-2011 St.
Mary’s Home: A unique Canadian community
outreach program providing obstetrical and post-partum contraceptive care for
pregnant adolescents.
Co-investigator